[1] Walani S R.Global burden of preterm birth[J].Int J Gynaecol Obstet, 2020, 150(1):31-33.
[2] Back SA.White matter injury in the preterm infant:pathology and mechanisms[J].Acta Neuropathol, 2017, 134(3):331-349.
[3] Panfoli I, Candiano G, Malova M, et al.Oxidative stress as a primary risk factor for brain damage in preterm newborns[J].Front Pediatr, 2018, 6:369.
[4] Guillen N, Llerena C, Samalvides S, et al.Risk of brain damage in premature infants under 34 weeks of gestational age exposed to histological chorioamnionitis Lima, peru[J].Rev Peru Med Exp Salud Publica, 2020, 37(2):229-238.
[5] Huang X, Fu J.Associationbetween assisted reproductive technology and white matter injury in premature infants:a case-control study[J].Front Pediatr, 2021, 9:686670.
[6] 岳艳,张莉,屈艺,等.少突胶质前体细胞移植对早产儿脑白质损伤的保护作用[J].中国当代儿科杂志,2018,20(4):326-331.
Yue Y, Zhang L, Qu Y, et al.Neuroprotective effects of oligodendrocyte precursor cells on white matter damage in preterm infants[J].Chin J Contemp Pediatr, 2018, 20(4):326-331.(in Chinese)
[7] Cai C, Ahmad T, Valencia GB, et al.Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver[J].Growth Horm IGF Res, 2018, 41:54-63.
[8] Forbes BE, Blyth AJ, Wit JM.Disorders of IGFs and IGF-1R signaling pathways[J].Mol Cell Endocrinol, 2020, 518:111035.
[9] Hellstrom W, Hortensius LM, Lofqvist C, et al.Postnatal serum IGF-1 levels associate with brain volumes at term in extremely preterm infants[J].Pediatr Res, 2022.
[10] Torres-Cuevas I, Corral-Debrinski M, Gressens P.Brain oxidative damage in murine models of neonatal hypoxia/ischemia and reoxygenation[J].Free Radic Biol Med, 2019, 142:3-15.
[11] Janowska J,Gargas J, Ziemka-Nalecz M, et al.Oligodendrocyte response to pathophysiological conditions triggered by episode of perinatal hypoxia-ischemia:Role of IGF-1 secretion by glial cells[J].Mol Neurobiol, 2020, 57(10):4250-4268.
[12] Zhou J, Terluk MR, Basso L, et al.N-acetylcysteine provides cytoprotection in murine oligodendrocytes through heme oxygenase-1 activity[J].Biomedicines, 2020, 8(8):240.
[13] Fern R, Matute C.Glutamate receptors and white matter stroke[J].Neurosci Lett, 2019, 694:86-92.
[14] Ness JK, Scaduto RC Jr, Wood TL.IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4⁺ oligodendrocyte progenitors[J].Glia, 2004, 46(2):183-194.
[15] Simonishvili S, Jain MR, Li H, et al.Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia[J].ASN Neuro, 2013, 5(5):e00131.
[16] Zhao B, Zheng Z.Insulingrowth factor 1 protects neural stem cells against apoptosis induced by hypoxia through Akt/mitogen-activated protein Kinase/extracellular signal-regulated kinase (Akt/MAPK/ERK) pathway in hypoxia-ishchemic encephalopathy[J].Med Sci Monit, 2017, 23:1872-1879.
[17] Shao R, Sun D, Hu Y, et al.White matter injury in the neonatal hypoxic-ischemic brain and potential therapies targeting microglia[J].J Neurosci Res, 2021, 99(4):991-1008.
[18] Pierre WC, Londono I, Quiniou C, et al.Modulatory effect of IL-1 inhibition following lipopolysaccharide-induced neuroinflammation in neonatal microglia and astrocytes[J].Int J Dev Neurosci, 2022, 82(3):243-260.
[19] Goshi N, Morgan RK, Lein PJ, et al.A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation[J].J Neuroinflammation, 2020, 17(1):155.
[20] Pinto-Benito D, Paradela-Leal C, Ganchala D, et al.IGF-1 regulates astrocytic phagocytosis and inflammation through the p110alpha isoform of PI3K in a sex-specific manner[J].Glia, 2022, 70(6):1153-1169.
[21] Zhou Y, Zhang J, Wang L, et al.Interleukin-1beta impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion[J].Brain Behav Immun, 2017, 60:93-105.
[22] Klevebro S, Hellgren G, Hansen-Pupp I, et al.Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants[J].Growth Horm IGF Res, 2020, 50:1-8.
[23] Liddelow SA, Guttenplan KA, Clarke LE, et al.Neurotoxic reactive astrocytes are induced by activated microglia[J].Nature, 2017, 541(7638):481-487.
[24] Breton JM, Long KLP, Barraza MK, et al.Hormonalregulation of oligodendrogenesis Ⅱ:Implications for myelin repair[J].Biomolecules, 2021, 11(2):290.
[25] Li QY, Miao Q, Sui RX, et al.Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis[J].Int Immunopharmacol, 2019, 75:105819.
[26] Shi B, Ding J, Liu Y, et al.ERK1/2 pathway-mediated differentiation of IGF-1-transfected spinal cord-derived neural stem cells into oligodendrocytes[J].PLoS One,2014, 9(8):e106038.
[27] Lorenzati M, Boda E, Parolisi R, et al.c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination[J].Sci Rep, 2021, 11(1):7264.
[28] Min J, Singh S, Fitzgerald-Bocarsly P, et al. Insulin-like growth factor Ⅰ regulates G2/M progression through mammalian target of rapamycin signaling in oligodendrocyte progenitors[J]. Glia,2012,60(11):1684-95.
[29] Bibollet-Bahena O, Almazan G.IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways[J].J Neurochem, 2009, 109(5):1440-1451.
[30] Gonsalvez D, Ferner AH, Peckham H, et al.The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination[J].Neuropharmacology, 2016, 110(Pt B):586-593.
[31] Ishii A, Furusho M, Macklin W, et al.Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood[J].Glia, 2019, 67(7):1277-1295.
[32] Wang H, Liu M, Ye Z, et al.Akt regulates sox10 expression to control oligodendrocyte differentiation via phosphorylating FoxO1[J].J Neurosci, 2021, 41(39):8163-8180.
[33] Srivastava T, Diba P, Dean JM, et al.A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors[J].J Clin Invest, 2018, 128(5):2025-2041.
[34] Liu X, Dong C, Liu K, et al.mTOR pathway repressing expression of FoxO3 is a potential mechanism involved in neonatal white matter dysplasia[J].Hum Mol Genet, 2022, 31(15):2508-2520.
[35] Watamoto Y, Futawaka K, Hayashi M, et al.IGF-1 regulate the expression of uncoupling protein 2 via FOXO1[J].Growth Factors, 2019, 37(5-6):247-256.
[36] Lin KN, Zhang K, Zhao W, et al.Insulin-like growth factor 1 promotes cell proliferation by downregulation of G-Protein-Coupled receptor 17 expression via PI3K/Akt/FoxO1 signaling in SK-N-SH cells[J].Int J Mol Sci, 2022, 23(3):1513.
[37] Vaes JEG, Kosmeijer CM, Kaal M, et al.Regenerative therapies to restore interneuron disturbances in experimental models of encephalopathy of prematurity[J].Int J Mol Sci, 2020, 22(1):211.
[38] Tien LT, Lee YJ, Pang Y, et al.Neuroprotective effects of intranasal IGF-1 against neonatal lipopolysaccharide-induced neurobehavioral deficits and neuronal inflammation in the substantia nigra and locus coeruleus of juvenile rats[J].Dev Neurosci, 2017, 39(6):443-459.
[39] Chung JK,Hallberg B,Hansen-Pupp I,et al.Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants[J].Pediatr Res, 2017, 81(3):504-510.
[40] Hellstrom A, Ley D, Hallberg B, et al.IGF-1 as a drug for preterm infants:A step-wise clinical development[J].Curr Pharm Des, 2017, 23(38):5964-5970.
[41] Lin S, Fan L-W, Pang Y, et al. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Research, 2005, 1063(1): 15-26.
[42] Lin S, Fan LW, Rhodes PG, et al. Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats[J]. Experimental neurology, 2009, 217(2): 361-370.
[43] Hellgren G, Han W, Wang X, et al. Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice[J]. Growth Horm IGF Res, 2011, 21(4):205-211.
[44] Gram M,Ekstrom C, Holmqvist B, et al. Insulin-like growth factor 1 in the preterm rabbit pup:Characterization of cerebrovascular maturation following administration of recombinant human insulin-like growth factor 1/insulin-like growth factor 1-binding protein 3[J]. Dev Neurosci, 2021, 43(5):281-295.
[45] Kalimuthu S, Oh JM, Gangadaran P, et al.Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer[J].PLoS One, 2017, 12(7):e0181318.
[46] Vaes JEG, Van Kammen CM, Trayford C, et al.Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity[J].Glia, 2021, 69(3):655-680.
[47] Chen S, Wang T, Yao J, et al.Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo:Therapeutic implication for alzheimer′s disease[J].Neurotherapeutics, 2020, 17(4):1813-1824.
[48] Gyetvai G, Hughes T, Wedmore F,et al.Erythropoietin increases myelination in oligodendrocytes:Gene expression profiling reveals early induction of genes involved in lipid transport and metabolism[J].Front Immunol, 2017, 8:1394.
[49] Steinman G, Mankuta D.Molecular biology of autism′s etiology-an alternative mechanism[J].Med Hypotheses, 2019, 130:109272.